Please login to the form below

Not currently logged in
Email:
Password:

American Society of Hematology

This page shows the latest American Society of Hematology news and features for those working in and with pharma, biotech and healthcare.

Takeda bags EU approval for Adcetris in lymphoma

Takeda bags EU approval for Adcetris in lymphoma

of new indications, and according to the biotech has the potential to cross the $1bn sales threshold. ... The ECHELON-1 data were reported at the American Society of Hematology (ASH) meeting in December and showed that Adcetris plus chemotherapy was more

Latest news

More from news
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    The survey provides an interesting snapshot of the current interests of this cohort. ... A brief glance at the programme for the major US haematology congress, held by the American Society of Hematology, tells its own story, with most sessions being

  • Deal Watch November 2016 Deal Watch November 2016

    Sun Pharma will also assume Biosintez's $36m debt as part of this transaction. ... This does not typically include royalty payments. 2. Ataga et al, Abstract, American Society of Hematology (ASH), December 2016.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics